AstraZeneca Says US COVID-19 Vaccine Trial Still On Hold By Reuters



[ad_1]

© Reuters. FILE PHOTO: The logo of the pharmaceutical company AstraZeneca is displayed on a screen on the floor of the New York Stock Exchange in New York.

(Reuters) – AstraZeneca Plc (L 🙂 said on Saturday that its COVID-19 vaccine trial in the United States is still on hold.

AstraZeneca published an https: // document on Saturday outlining details of how the COVID-19 vaccine trial was being conducted, which was first reported by the New York Times.

Disclaimer: Fusion Media I would like to remind you that the data contained in this website is not necessarily real time or accurate. All CFDs (stocks, indices, futures) and Forex prices are not provided by exchanges but by market makers, so the prices may not be accurate and may differ from the actual market price, which means that prices are indicative and not appropriate for commercial purposes. Therefore, Fusion Media assumes no responsibility for any business losses you may incur as a result of the use of this data.

Fusion Media or anyone involved with Fusion Media will not accept any responsibility for loss or damage as a result of reliance on information, including data, quotes, charts and buy / sell signals contained on this website. Be fully informed about the risks and costs associated with trading financial markets, it is one of the riskiest investment forms possible.



[ad_2]